A reduction of IGF-1 serum levels in the Hz group was found, which was normalized by IGF-1 therapy
Designed for adults with obesity or overweight conditions, tirzepatide offers a new approach to managing significant health challenges such as obstructive sleep apnea, chronic kidney disease, and cardiovascular disease, all of which are exacerbated by obesity
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters
Additionally, our Lexington semaglutide treatment slows the movement of food through the digestive system, contributing to feelings of fullness and stabilizing blood sugar levels
Estimating glomerular filtration rate from serum creatinine and cystatin C
Apperloo EM, Neuen BL, Fletcher RA, Jongs N, Anker SD, Bhatt DL, et al